The impact of high serum bicarbonate levels on mortality in hemodialysis patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The optimal serum bicarbonate level is controversial for patients who are undergoing hemodialysis (HD). In this study, we analyzed the impact of serum bicarbonate levels on mortality among HD patients. Methods: Prevalent HD patients were selected from the Clinical Research Center registry for End Stage Renal Disease cohort in Korea. Patients were categorized into quartiles according to their total carbon dioxide (tCO2) levels: quartile 1, a tCO2 of < 19.4 mEq/L; quartile 2, a tCO2 of 19.4 to 21.5 mEq/L; quartile 3, a tCO2 of 21.6 to 23.9 mEq/L; and quartile 4, a tCO2 of ≥ 24 mEq/L. Cox regression analysis was used to calculate the adjusted hazard ratio (HR) and confidence interval (CI) for mortality. Results: We included 1,159 prevalent HD patients, with a median follow-up period of 37 months. Kaplan-Meier analysis revealed that the all-cause mortality was significantly higher in patients from quartile 4, compared to those from the other quartiles (p = 0.009, log-rank test). The multivariate Cox proportional hazard model revealed that patients from quartile 4 had significantly higher risk of mortality than those from quartile 1, 2 and 3, after adjusting for the clinical variables in model 1 (HR, 1.99; 95% CI, 1.15 to 3.45; p = 0.01) and model 2 (HR, 1.82; 95% CI, 1.03 to 3.22; p = 0.04). Conclusions: Our data indicate that high serum bicarbonate levels (a tCO2 of ≥ 24 mEq/L) were associated with increased mortality among prevalent HD patients. Further effort might be necessary in finding the cause and correcting metabolic alkalosis in the chronic HD patients with high serum bicarbonate levels.
Abstract
Background/Aims: The optimal serum bicarbonate level is controversial for patients who are undergoing hemodialysis (HD). In this study, we analyzed the impact of serum bicarbonate levels on mortality among HD patients. Methods: Prevalent HD patients were selected from the Clinical Research Center registry for End Stage Renal Disease cohort in Korea. Patients were categorized into quartiles according to their total carbon dioxide (tCO2) levels: quartile 1, a tCO2 of < 19.4 mEq/L; quartile 2, a tCO2 of 19.4 to 21.5 mEq/L; quartile 3, a tCO2 of 21.6 to 23.9 mEq/L; and quartile 4, a tCO2 of ≥ 24 mEq/L. Cox regression analysis was used to calculate the adjusted hazard ratio (HR) and confidence interval (CI) for mortality. Results: We included 1,159 prevalent HD patients, with a median follow-up period of 37 months. Kaplan-Meier analysis revealed that the all-cause mortality was significantly higher in patients from quartile 4, compared to those from the other quartiles (p = 0.009, log-rank test). The multivariate Cox proportional hazard model revealed that patients from quartile 4 had significantly higher risk of mortality than those from quartile 1, 2 and 3, after adjusting for the clinical variables in model 1 (HR, 1.99; 95% CI, 1.15 to 3.45; p = 0.01) and model 2 (HR, 1.82; 95% CI, 1.03 to 3.22; p = 0.04). Conclusions: Our data indicate that high serum bicarbonate levels (a tCO2 of ≥ 24 mEq/L) were associated with increased mortality among prevalent HD patients. Further effort might be necessary in finding the cause and correcting metabolic alkalosis in the chronic HD patients with high serum bicarbonate levels.
참고문헌 (18)
- Levin A, "Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward", Kidney Int, 85, pp.49~61 (2014)
- Tentori F, "Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)", Am J Kidney Dis, 62, pp.738~746 (2013)
- Chen W, "Treatment of metabolic acidosis in patients with CKD", Am J Kidney Dis, 63, pp.311~317 (2014)
- Uribarri J, "Association of acidosis and nutritional parameters in hemodialysis patients", Am J Kidney Dis, 34, pp.493~499 (1999)
- Heguilen RM, "The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients", Nephrol Dial Transplant, 20, pp.591~597 (2005)
- Di Iorio B, "Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis:pilot study of single dialysis effects", J Nephrol, 25, pp.653~667 (2012)
- Sethi D, "Acute metabolic alkalosis during haemodialysis", Nephron, 51, pp.119~120 (1989)
- Kaye M, "Hypocalcemic tetany and metabolic alkalosis in a dialysis patient: an unusual event", Am J Kidney Dis, 30, pp.440~444 (1997)
- Bommer J, "Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS)", Am J Kidney Dis, 44, pp.661~671 (2004)
- Wu DY, "Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic?", Clin J Am Soc Nephrol, 1, pp.70~78 (2006)
- Vashistha T, "Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality", Clin J Am Soc Nephrol, 8, pp.254~264 (2013)
- Depner TA, "Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics", J Am Soc Nephrol, 7, pp.780~785 (1996)
- Gabutti L, "Unexpected haemodynamic instability associated with standard bicarbonate haemodialysis", Nephrol Dial Transplant, 18, pp.2369~2376 (2003)
- Graham KA, "Pre and interdialytic acid-base balance in hemodialysis patients", Int J Artif Organs, 24, pp.192~196 (2001)
- Pifer TB, "Mortality risk in hemodialysis patients and changes in nutritional indicators:DOPPS", Kidney Int, 62, pp.2238~2245 (2002)
- Mapes DL, "Health-related quality of life as a predictor of mortality and hospitalization:the Dialysis Outcomes and Practice Patterns Study (DOPPS)", Kidney Int, 64, pp.339~349 (2003)
- Leavey SF, "Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients", Kidney Int, 58, pp.2119~2128 (2000)
- Thet Z, "Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis", BMC Nephrol, 14, pp.205~ (2013)